- Home
- PANW vs BDX Comparison
PANW vs BDX Comparison
Compare PANW & BDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PANW
- BDX
- Stock Information
- Founded
- PANW 2005
- BDX 1897
- Country
- PANW United States
- BDX United States
- Employees
- PANW N/A
- BDX N/A
- Industry
- PANW Computer peripheral equipment
- BDX Medical/Dental Instruments
- Sector
- PANW Technology
- BDX Health Care
- Exchange
- PANW Nasdaq
- BDX Nasdaq
- Market Cap
- PANW 56.1B
- BDX 57.9B
- IPO Year
- PANW 2012
- BDX 1962
- Fundamental
- Price
- PANW $167.69
- BDX $198.71
- Analyst Decision
- PANW Buy
- BDX Strong Buy
- Analyst Count
- PANW 46
- BDX 7
- Target Price
- PANW $204.93
- BDX $275.71
- AVG Volume (30 Days)
- PANW 6.5M
- BDX 2.5M
- Earning Date
- PANW 05-19-2025
- BDX 05-01-2025
- Dividend Yield
- PANW N/A
- BDX 2.08%
- EPS Growth
- PANW N/A
- BDX 41.25
- EPS
- PANW 1.77
- BDX 5.94
- Revenue
- PANW $8,570,500,000.00
- BDX $20,640,000,000.00
- Revenue This Year
- PANW $16.54
- BDX $9.27
- Revenue Next Year
- PANW $14.98
- BDX $4.98
- P/E Ratio
- PANW $94.64
- BDX $33.44
- Revenue Growth
- PANW 13.86
- BDX 5.89
- 52 Week Low
- PANW $137.60
- BDX $193.03
- 52 Week High
- PANW $208.39
- BDX $251.99
- Technical
- Relative Strength Index (RSI)
- PANW 45.20
- BDX 31.89
- Support Level
- PANW $161.45
- BDX $193.03
- Resistance Level
- PANW $174.94
- BDX $206.78
- Average True Range (ATR)
- PANW 8.19
- BDX 8.05
- MACD
- PANW 0.95
- BDX -1.51
- Stochastic Oscillator
- PANW 76.45
- BDX 15.45
About PANW Palo Alto Networks Inc.
Palo Alto Networks is a platform-based cybersecurity vendor with product offerings covering network security, cloud security, and security operations. The California-based firm has more than 80,000 enterprise customers across the world, including more than three fourths of the Global 2000.
About BDX Becton Dickinson and Company
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (27% of 2024 revenue) and BD Interventional (24%) account for the remainder. International revenue accounts for 43% of the company's business.